Table 2.
Patient-Reported Outcomes: Ratings of Rosacea Improvement at Week 12
| Patient ratings of rosacea improvement | Study 1 | Study 2 | ||
|---|---|---|---|---|
| Ivermectin 1% cream, % (N = 451) |
Vehicle cream, % (N = 232) |
Ivermectin 1% cream, % (N = 459) |
Vehicle cream, % (N = 229) |
|
| Excellent | 34 | 10 | 32 | 7 |
| Good | 35 | 29 | 34 | 27 |
| Moderate | 20 | 31 | 22 | 35 |
| No improvement | 8 | 25 | 10 | 25 |
| Worse | 3 | 6 | 3 | 6 |
| P value | <.001 | <.001 | ||
NOTE: The totals of each study arm may not equal 100% because of rounding.
Source: Stein Gold L, Kircik L, Fowler J, et al. Efficacy and safety of ivermectin 1% cream in treatment of papulopustular rosacea: results of two randomized, double-blind, vehicle-controlled pivotal studies. J Drugs Dermatol. 2014;13:316–323.